Risk factors of skeletal-related events in patients with bone metastasis from non-small cell lung cancer undergoing treatment with zoledronate-a post hoc analysis of a randomized clinical trial.

Hirotaka MiyashitaChristina CruzCardinale Smith

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2020)

We revealed that osteolytic bone metastasis, low serum albumin, and elevated serum ALP are risk factors for SREs in patients with bone metastasis from NSCLC.

Keyphrases

bone mineral density
risk factors
soft tissue
bone loss
small cell lung cancer
bone regeneration
body composition
tyrosine kinase